Skip to main content

letter

. 1996 Mar 30;312(7034):846–847. doi: 10.1136/bmj.312.7034.846a

Misoprostol in patients taking non-steroidal anti-inflammatory drugs. Analysis excluded in important events.

M J Shield, S V Morant

PMCID: PMC2350699 PMID: 8608308

846

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cook R. J., Sackett D. L. The number needed to treat: a clinically useful measure of treatment effect. BMJ. 1995 Feb 18;310(6977):452–454. doi: 10.1136/bmj.310.6977.452. [DOI] [PMC free article] [PubMed] [Google Scholar]
Laupacis A., Sackett D. L., Roberts R. S. An assessment of clinically useful measures of the consequences of treatment. N Engl J Med. 1988 Jun 30;318(26):1728–1733. doi: 10.1056/NEJM198806303182605. [DOI] [PubMed] [Google Scholar]
Maiden N., Madhok R. Misoprostol in patients taking non-steroidal anti-inflammatory drugs. BMJ. 1995 Dec 9;311(7019):1518–1519. doi: 10.1136/bmj.311.7019.1518. [DOI] [PMC free article] [PubMed] [Google Scholar]
Silverstein F. E., Graham D. Y., Senior J. R., Davies H. W., Struthers B. J., Bittman R. M., Geis G. S. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1995 Aug 15;123(4):241–249. doi: 10.7326/0003-4819-123-4-199508150-00001. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES